Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage
SAGA Metals Reports Assays from R-0044 to R-0046 with Intercepts Including 58.33% Fe2O3, 8.78% TiO2, 0.415% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Nuvau Expands Its Exploration Program Targeting Key Base Metal and Never-Before-Drilled Gold Targets in the Matagami District
